Adagene Inc.
ADAG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818838
In the last 90 days, Adagene Inc. insiders filed 4 open-market purchases and 0 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $81.0M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Adagene Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 10 | 11 | +1 |
| Shares | 4.10M | 7.12M | +3.03M (+73.9%) |
| Value | $6.16M | $15.5M | +$9.35M (+151.7%) |
New holders (2)
Institutions that held Adagene Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| WuXi AppTec Co., Ltd. | 4,225,696 | $8.16M | 21.16% |
| UBS Group AG | 1 | $2 | 0.00% |
Sold out (1)
Institutions that held Adagene Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Strategic Vision Investment Ltd | 239,317 | $366.2K |